AC Immune SA business relationships
Companies named in AC Immune SA’s 20-F filed 2026-03-13, and public companies whose annual reports name AC Immune SA. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 5.4 / 10
- AI naming
- 73 / 100 Top 2% in its category
- Agent readiness
- 35 / 100
- AI adoption
- 0 / 100
Layers: Peptides
Named in AC Immune SA’s annual report 8
“ACI-24.060 is the subject of an exclusive option and license agreement with Takeda.” SEC filing
“AC Immune regained the global rights to crenezumab in February 2025, following termination of the collaboration agreement with Genentech, a member of the Roche Group, which termination became effective in April 2024.” SEC filing
“...t gains and losses that arise from our cash being held in currency other than Swiss Francs, certain collaboration agreements such as the collaboration agreements with LMI or Takeda being denominated in currencies other than Swiss Francs, and selected purchases, which we effect in foreign currencies.” SEC filing
“Morphomer Tau small molecule - 2018 license agreement with Eli Lilly and Company” SEC filing
“Lastly, our collaboration agreements with Lilly, Janssen, Lantheus and Takeda (in the case of Takeda, if it exercises its option under our agreement) provide each partner with control over, and responsibility for, the clinical development process, including obtaining regulatory and marketing approva...” SEC filing
“We also have a diagnostic partnership with Lantheus for compounds, which bind pathological Tau for use as a PET tracer.” SEC filing
“| | ● | | a worldwide licensing agreement with Genentech signed in June 2012 (and amended in December 2015) for anti-Tau antibodies to treat AD.” SEC filing
“We entered into a strategic collaboration with Genentech in November 2006 (as amended in March 2009, January 2013, May 2014 and May 2015) regarding the development, manufacture and commercialization of anti-Abeta antibodies including crenezumab, and we refer to this agreement as the 2006 Agreement.” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.